Pharmafile Logo
Pharmafocus logo
Advanced Search
handshake2

Sanofi and Alynylam rejig sees global rights switch-up

January 8, 2018
Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical

The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …

News
shutterstock_158366573

The PROs and cons of pushing patient centricity

January 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …

Feature
amgen_flag

FDA clears Amgen’s bone drug for multiple myeloma

January 8, 2018
Sales and Marketing Amgen, Cancer, Xgeva, multiple myeloma, pharma

Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment …

News
celgene_exteriors-3

Celgene in $7bn shot on Impact

January 8, 2018
Sales and Marketing Celgene, Impact Biomedicines, biotech, drugs, pharma, pharmaceutical

Billions of dollars do not often get put down for drugs that have been dropped by a major pharma company, …

News
ablynx_flags-web

Novo Nordisk ups acquisition bid to €2.6 billion, Ablynx says no

January 8, 2018
Sales and Marketing Ablynx, Novo Nordisk, acquisition, pharma

It has emerged that Novo Nordisk has extended a bid of €2.6 billion to buy Belgian biotech Ablynx. The new …

News

Pfizer exits neuroscience R&D space

January 8, 2018
Research and Development, Sales and Marketing Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer announced over the weekend that it would be backing out of research and development into the neuroscience area, abandoning …

News
spmsdsite

Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds

January 5, 2018
Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …

News
davidepsteinheadshot_

Novartis Pharma Ex-CEO takes three roles in two days

January 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Epstein, Flagship Pioneering, biotech, drugs, pharma, pharmaceutical

Former CEO of Novartis Pharmaceuticals, David Epstein, has had a busy start to the year, accepting not one but three …

Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, J&J, JJ, NICE, Pfizer, Spark Therapeutics, Valeant, top ten

Happy New Year from Pharmafile.com! We hope the first week of 2018 hasn’t been too rough. To the surprise of …

News

Takeda agrees $630m takeover of TiGenix

January 5, 2018
Medical Communications, Sales and Marketing Takeda, TiGenix, biotech, drugs, pharma, pharmaceutical

Takeda already had a strong working relationship with TiGenix, after previously signing a licensing agreement with the Belgium-based pharma company …

News
syneos_health_rgb_tm

INC Research and inVentiv merge to form Syneos Health

January 4, 2018
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing INC Research, Syneos Health, inVentiv Health

With the advent of the new year, INC Research and inVentiv Health have announced they are to merge operations under …

News
j_mendlein

Moderna Therapeutics names Dr John Medlein as new President, Corporate and Product Strategy

January 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moderna, Moderna Therapeutics, mrna

Messenger RNA (mRNA) therapeutics and vaccines specialist Moderna Therapeutics has announced the appointment of current board member Dr John Medlein …

Appointment
reovirus_-_credit_nih

Common virus able to target brain cancer

January 4, 2018
Medical Communications, Research and Development biotech, brain cancer, drugs, pharma, pharmaceutical

Research emerging from the University of Leeds and The Institute of Cancer research has revealed that a virus, known as …

News
nice_new_london_office_internal_3_web

NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy

January 4, 2018
Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma

NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …

News
pfizer_chrome_plate

Pfizer makes $830m drug discovery pact with Arvinas

January 4, 2018
Research and Development, Sales and Marketing Arvinas, Pfizer, biotech, drugs, pharma, pharmaceutical

Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing …

News
artificial-intelligence-2228610_640

New AI system for lung cancer and heart disease could save NHS billions

January 4, 2018
Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma

A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …

News
allergan-westport-ireland_web

Allergan to axe over 1,000 positions in cost cutting measures

January 4, 2018
Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan was never far away from the headlines in 2017, particularly when it came to its second highest selling product, …

News
kress

Syntimmune brings in new CEO from Biogen

January 4, 2018
Syntimmune, biotech, drugs, pharma, pharmaceutical

Syntimmune has revealed that it has brought in a new CEO to begin the new year, with the appointment of …

Appointment
eye-1173863_960_720

Spark’s bright idea on $850,000 blindness gene therapy

January 3, 2018
Sales and Marketing : Pharma, Spark Therapeutics, biotech, drugs, pharma, pharmaceutical

Spark Therapeutics knew that it had to think very carefully about where it pitched its price for its inarguably ground-breaking …

News

J&J’s predicted blockbuster depression posts P2 data

January 3, 2018
Research and Development Johnson & Johnson, biotech, depression, drugs, pharma, pharmaceutical

Johnson & Johnson has revealed Phase 2 data for its treatment for depression, esketamine, and the results are positive. The …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026